chevron_leftBack
As of 13 June 2026, Camp4 Therapeutics Corp. has a market cap of $206.64M USD, ranking #20860 globally and #3408 in the United States.
It ranks #1871 in the Healthcare sector, and #361 in the Biotechnology industry.
Key Stats
Market Cap
$206.64MUSD
Enterprise Value
$114.18MUSD
Revenue (TTM)
$3.5MUSD
EBITDA (TTM)
-$50.42MUSD
Net Income (TTM)
-$80.4MUSD
PS Ratio
63.4
PB Ratio
4.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Joshua Mandel-Brehm
open_in_new
Employees
48
Founded
2016
IPO
11 Oct 2024
Website
camp4tx.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -6.8% | -13% | -7.7% | -0.5% | 1.8% | 116% |
News
Loading...
CAMP Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
CAMP
Camp4 Therapeutics Corp
ISIN: US13463J1016
Shares Out.:
Shares Outstanding:
51.926M1
Shares Float:
26.517M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
3.98 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Camp4 Therapeutics Corp.
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
88K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
77K%
|
19.0
|
|
NASDAQ: NTRA
|
$27.6B
13K%
|
-
|
|
NYSE: IQV
|
$26.3B
13K%
|
20.0
|
|
NASDAQ: UTHR
|
$25.03B
12K%
|
20.4
|
|
NASDAQ: MRNA
|
$18.13B
9K%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
EBR: ARGX
|
$47.84B
23K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.84B
22K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.36B
20K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.3B
20K%
33.71B CHF
|
37.2
|
|
KRX: 068270
|
$28.11B
14K%
42.76T KRW
|
43.8
|
|
NASDAQ: BNTX
|
$25.69B
12K%
|
-
|
chevron_leftBack